Hepatotoxicity of Avacopan: Real‐World Incidence and Confirmed Cases of Severe Drug‐Induced Liver Injury in a US National Rheumatology Registry

Study limitation reported by the research below: “The study is ongoing in a regulatory context (FDA market withdrawal request declined); findings may be updated as the situation evolves.”